If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Accounting standards

1 Jul 2019 07:07

RNS Number : 9768D
Compagnie de Saint-Gobain
01 July 2019
 

 PRESS RELEASE

July 1st, 2019

 

SAINt-Gobain: Impact of ifrs 16 application

 

The Group has chosen to apply IFRS 16 using the full retrospective method at January 1, 2019, with retroactive effect from January 1, 2018. IFRS 16 aligns the accounting treatment of operating leases with that of finance leases (subject to the exemptions set out in the standard). The impact of IFRS 16 on the Group's consolidated financial statements arises chiefly from leases of property assets.

 

Applying this standard will result in a change in presentation in the consolidated financial statements for the six months ended June 30, 2019, with restatement of first-half 2018:

- In the balance sheet: a liability will be recognized in respect of future lease payments and an asset will be recognized in respect of the right-of-use granted (net value). The difference between these two amounts will be recognized in equity.

In the income statement: the rental expense previously recognized within operating income will partly be recorded in depreciation and amortization expense, and partly in net financial expense.

 

Based on the lease contracts analyzed, the Group estimates that the impact at the transition date is €3,011 million on debt and €2,744 million on right-of-use assets.

 

The full-year 2018 impact is an increase of +€787 million in EBITDA and +€85 million on operating income as detailed below with the new reporting segments following the Group organization change as of January 1, 2019.

 

Operating income

H1 2018(€m)

2018(€m)

H1 2018(in % of sales)

2018(in % of sales)

Post IFRS 16

 

 

 

 

High Performance Solutions

532

986

14.4%

13.4%

Northern Europe

388

856

5.2%

5.6%

Southern Europe - ME & Africa

293

603

4.4%

4.6%

Americas

235

578

9.1%

11.2%

Asia-Pacific

85

194

9.3%

10.4%

Misc.

-19

-10

---

---

Group total post IFRS 16

1,514

3,207

7.3%

7.7%

 

 

 

 

 

Group total pre IFRS 16

1,469

3,122

7.1%

7.5%

Delta IFRS 16

45

85

0.2%

0.2%

 

Post IFRS 16

 

 

 

 

Industry Europe

397

777

7.9%

7.8%

Distribution Europe

284

682

3.0%

3.6%

 

Disclaimer: the data presented are currently being reviewed by the statutory auditors.

ABOUT SAINT-GOBAIN

Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in our living places and our daily life: in buildings, transportation, infrastructure and in many industrial applications. They provide comfort, performance and safety while addressing the challenges of sustainable construction, resource efficiency and climate change.

 

€41.8 billion in sales in 2018

Operates in 68 countries

More than 180,000 employees

 

To learn more about Saint-Gobain

go to www.saint-gobain.com

 

 

 

Contacts analystes, investisseurs

 

 

Contacts presse

Vivien Dardel

Floriana Michalowska

Christelle Gannage

+33 1 47 62 44 29

 +33 1 47 62 35 98

 +33 1 47 62 30 93

Laurence Pernot

Patricia Marie

Susanne Trabitzsch

+33 1 47 62 30 10

+33 1 47 62 51 37

+33 1 47 62 43 25

    
 
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAKXFEESNEEF
Date   Source Headline
15th Sep 20146:30 pmRNSFinal Terms
5th Sep 20148:01 amRNSJV Saint-Gobain Central Glass in Indonesia
8th Aug 20144:07 pmRNSProspectus supplement
1st Aug 20148:34 amRNSAcquisition
30th Jul 20145:27 pmRNSH1-2014 Results
28th Jul 20147:52 amRNSNew contracts in Qatar
18th Jul 20148:13 amRNSPublication of Prospectus
7th Jul 20145:43 pmRNSAgreement Saint-Gobain / EBRD
2nd Jul 20145:10 pmRNSResult of the 2013 scrip dividend
17th Jun 201410:25 amRNSAcquisition
5th Jun 20146:21 pmRNSAdoption of all resolutions & reappointment of CEO
3rd Jun 20148:15 amRNSJoin Venture
29th Apr 20145:03 pmRNS1st Quarter Results
11th Apr 20144:54 pmRNSDisposal
27th Mar 20149:22 amRNSDecision of the General Court of the EU
4th Mar 20149:19 amRNSProspectus Supplement
19th Feb 20146:08 pmRNSFinal Results
19th Dec 20134:46 pmRNSDisposal
17th Dec 20134:49 pmRNSundrawn bank facilities
4th Dec 20134:50 pmRNSAcquisition
2nd Dec 20134:46 pmRNSSecuritisation programme
28th Nov 20137:00 amRNSFinal Terms
28th Nov 20137:00 amRNSFinal Terms
27th Nov 20136:08 pmRNSInvestor Meeting
25th Nov 20137:00 amRNSFinal Terms
25th Nov 20137:00 amRNSFinal terms
25th Nov 20137:00 amRNSFinal Terms
22nd Nov 20137:00 amRNSDirector renewal
24th Oct 20134:46 pmRNS3rd Quarter Results
30th Sep 20135:53 pmRNSFinal Terms
30th Sep 20137:00 amRNSR&D Center
6th Aug 20137:00 amRNSProspectus supplement
31st Jul 20133:23 pmRNSH1-2013 Financial Report
24th Jul 20135:10 pmRNSHalf Year Results
18th Jul 20138:40 amRNSProspectus
11th Jul 201311:30 amRNSNew plant in Russia
3rd Jul 20134:58 pmRNS2012 dividend
2nd Jul 20138:34 amRNSDisposal
6th Jun 20136:34 pmRNSFinal Terms
6th Jun 20136:25 pmRNSAGM Statement
30th May 20131:28 pmRNSCORRECTIONS TO FINAL TERMS
25th Apr 20135:16 pmRNS1st Quarter Results
9th Apr 20135:11 pmRNSContract in Kuwait
5th Apr 20132:43 pmRNSFinal Terms
5th Apr 20132:43 pmRNSFinal Terms
2nd Apr 201311:08 amRNSDoc Re: Prospectus Supplement
18th Mar 201310:23 amRNSFY 2012 Consolidated Financial Statements
7th Mar 20139:00 amRNSDisposal
6th Mar 20134:48 pmRNSNew plant
21st Feb 20137:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.